# MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD

MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD is a security (CUSIP 61559X104) tracked across SEC portfolio filings. 161 institutional managers reported $1.2B on Form 13F as of 2026-06-30; 9 registered fund positions totaling $20.9M via N-PORT as of 2026-05-31.

## Summary

- Issuer: MOONLAKE IMMUNOTHERAPEUTICS
- Class: CLASS A ORD
- CUSIP: 61559X104
- Asset category: EC
- 13F holders: 161
- 13F value: $1.2B
- 13F period: 2026-06-30
- N-PORT fund positions: 9
- N-PORT value: $20.9M
- N-PORT report: 2026-05-31

## Top institutional holders (Form 13F)

_Showing 15 of 161 managers by value._

| Manager | Location | Value | Shares |
| --- | --- | --- | --- |
| BVF INC/IL | San Francisco, CA | $298.3M | 16,001,284 |
| Deep Track Capital, LP | GREENWICH, CT | $119.5M | 6,408,863 |
| [Cormorant Asset Management, LP](https://search.stillhousedata.com/firm/167820) | BOSTON, MA | $83.5M | 4,480,433 |
| JANUS HENDERSON GROUP PLC | LONDON, X0 | $64.3M | 3,451,628 |
| D. E. Shaw & Co., Inc. | New York, NY | $44.6M | 2,390,661 |
| [CITADEL ADVISORS LLC](https://search.stillhousedata.com/firm/148826) | MIAMI, FL | $38.8M | 1,323,728 |
| [MPM BIOIMPACT LLC](https://search.stillhousedata.com/firm/309865) | BOSTON, MA | $33.8M | 1,811,082 |
| Weiss Asset Management LP | BOSTON, MA | $31.8M | 1,708,328 |
| [Logos Global Management LP](https://search.stillhousedata.com/firm/305162) | San Francisco, CA | $28.0M | 1,500,000 |
| [Point72 Asset Management, L.P.](https://search.stillhousedata.com/firm/283077) | Stamford, CT | $25.5M | 1,368,518 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | BALA CYNWYD, PA | $22.5M | 341,424 |
| GOLDMAN SACHS GROUP INC | NEW YORK, NY | $21.1M | 1,130,233 |
| [TWO SIGMA INVESTMENTS, LP](https://search.stillhousedata.com/firm/137137) | New York, NY | $20.9M | 1,122,312 |
| [Balyasny Asset Management L.P.](https://search.stillhousedata.com/firm/138111) | Chicago, IL | $19.9M | 1,065,610 |
| BlackRock, Inc. | New York, NY | $19.0M | 1,021,851 |

## Top fund holders (N-PORT)

| Fund | Registrant | Value | % of fund |
| --- | --- | --- | --- |
| [T. Rowe Price Health Sciences Fund, Inc.](https://search.stillhousedata.com/fund/S000002088) | T. ROWE PRICE HEALTH SCIENCES FUND, INC. | $16.5M | 15.18% |
| [HARTFORD SMALL CAP GROWTH HLS FUND](https://search.stillhousedata.com/fund/S000004108) | HARTFORD HLS SERIES FUND II INC | $1.8M | 22.93% |
| [T. Rowe Price Health Sciences Portfolio](https://search.stillhousedata.com/fund/S000002083) | T. ROWE PRICE EQUITY SERIES, INC. | $1.0M | 15.21% |
| [Fidelity Nasdaq Composite Index ETF](https://search.stillhousedata.com/fund/S000006011) | Fidelity Commonwealth Trust | $589K | 0.54% |
| BlackRock Health Sciences Term Trust | BlackRock Health Sciences Term Trust | $524K | 5.18% |
| [Victory RS Small Cap Growth Equity VIP Series](https://search.stillhousedata.com/fund/S000053585) | Victory Variable Insurance Funds | $211K | 39.17% |
| [BlackRock Advantage SMID Cap Fund, Inc.](https://search.stillhousedata.com/fund/S000002323) | BlackRock Advantage SMID Cap Fund, Inc. | $127K | 1.69% |
| BlackRock Health Sciences Trust | BlackRock Health Sciences Trust | $110K | 2.07% |
| [Blackstone Alternative Multi-Strategy Fund](https://search.stillhousedata.com/fund/S000045538) | Blackstone Alternative Investment Funds | $71K | 0.20% |

## More

- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/security/61559X104.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.